AstraZeneca acquires specialty pharma company Omthera for $323 million
09:29 AM | May 28, 2013 | Natasha Alperowicz
AstraZeneca today announced that it has agreed to acquire Omthera Pharmaceuticals (Princeton, NJ), a specialty pharmaceutical company focused on the development and commercialization of new therapies...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.